The release of a soft adjusted EPS guidance suggests that Humana may face challenges in meeting its financial targets, which can lead to a loss of investor confidence and a decrease in stock price. As earnings guidance is a significant indicator of a company's future performance, this news is directly relevant and important to Humana's investors, and the confidence in this analysis is high due to the typical market reaction to such announcements.